News Website

First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central

First immunotherapy combination for endometrial cancer approved by NICE Oncology Central

Published: Aug. 6, 2025, 11:18 a.m.

Read Full Article

First immunotherapy for advanced endometrial cancer approved in the UK - Open Access Government

First immunotherapy for advanced endometrial cancer approved in the UK Open Access Government

Published: Aug. 6, 2025, 8:50 a.m.

Read Full Article

NICE approves first immunotherapy combination for endometrial cancer - NICE website

NICE approves first immunotherapy combination for endometrial cancer NICE website

Published: Aug. 5, 2025, 11 p.m.

Read Full Article

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight - The Malaysian Reserve

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight The Malaysian Reserve

Published: July 24, 2025, 10:55 p.m.

Read Full Article

Gastric ectopic pancreatic ductal adenocarcinoma coexisted with endometriosis mimick advanced disease: a case report and literature review.

Ectopic pancreas (EP) is most commonly located in the upper gastrointestinal tract, particularly in the stomach. Malignant transformation of EP is exceptionally rare, and due to its very low incidence, …

Published: July 24, 2025, midnight

Read Full Article

chemotherapy ectopic pancreas immunotherapy malignancy stomach

Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy - Labroots

Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy Labroots

Published: July 14, 2025, 10 a.m.

Read Full Article

Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers - MedPage Today

Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers MedPage Today

Published: July 3, 2025, 3 p.m.

Read Full Article

Endometrial Cancer - Pipeline Insight, 2025: Immunotherapy - openPR.com

Endometrial Cancer - Pipeline Insight, 2025: Immunotherapy openPR.com

Published: June 30, 2025, 6:49 p.m.

Read Full Article

Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer - Medical Xpress

Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer Medical Xpress

Published: June 2, 2025, 6:20 p.m.

Read Full Article

Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer | Newswise - Newswise

Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer | Newswise Newswise

Published: June 2, 2025, 2:25 p.m.

Read Full Article

Latest Articles

First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central

First immunotherapy for advanced endometrial cancer approved in the UK - Open Access Government

NICE approves first immunotherapy combination for endometrial cancer - NICE website

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight - The Malaysian Reserve

Gastric ectopic pancreatic ductal adenocarcinoma coexisted with endometriosis mimick advanced disease: a case report and literature review.

Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy - Labroots

Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers - MedPage Today

Endometrial Cancer - Pipeline Insight, 2025: Immunotherapy - openPR.com

Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer - Medical Xpress

Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer | Newswise - Newswise

Subscribe to Our Newsletter